SCOPUS 정보 검색 플랫폼

Expert Opinion on Therapeutic Patents

Volumn 19, Issue 10, 2009, Pages 1469-1472

A novel Syk kinase inhibitor suitable for inhalation: R-343(?) - WO-2009031011

(1) Norman, Peter a

a NORMAN CONSULTING (United Kingdom)

Author keywords

Allergy; Asthma; PF 03526299; R 343; Syk kinase

Indexed keywords

PROTEIN KINASE SYK; PROTEIN KINASE SYK INHIBITOR; R 343; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; CLINICAL TRIAL; DRUG FORMULATION; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; IC 50; NONHUMAN; SHEEP; SHORT SURVEY;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BENZOXAZINES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR STRUCTURE; PATENTS AS TOPIC; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349760181 PISSN: 13543776 EISSN: None Source Type: Journal
DOI: 10.1517/13543770903059281 Document Type: Short Survey

Times cited : (18)

References (13)

1
- 70349757589
- Kinase inhibitor pipelines
- Norman P. Kinase inhibitor pipelines, CHI insight pharma reports December 2007
- CHI Insight Pharma Reports December 2007
- Norman, P.¹

2
- 61849130484
- The tyrosine kinase network regulating mast cell activation
- Gilfillan AM, Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol Rev 2009;228(1):149-169
- (2009) Immunol Rev , vol.228 , Issue.1 , pp. 149-169
- Gilfillan, A.M.¹ Rivera, J.²

3
- 67449097103
- Syk kinase inhibitors in allergic diseases
- Denyer J, Patel V. Syk kinase inhibitors in allergic diseases. Drug News Perspect 2009;22(3):146-150
- (2009) Drug News Perspect , vol.22 , Issue.3 , pp. 146-150
- Denyer, J.¹ Patel, V.²

4
- 2442538795
- Modulation of the Fcε receptor I signaling by tyrosine kinase inhibitors: Search for therapeutic targets of inflammatory and allergy diseases
- DOI 10.2174/1381612043384538
- Lusková P, Dráber P. Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharm Des 2004;10(15):1727-1737 (Pubitemid 38647455)
- (2004) Current Pharmaceutical Design , vol.10 , Issue.15 , pp. 1727-1737
- Luskova, P.¹ Draber, P.²

5
- 0041932075
- The orally available spleen tyrosine kinase inhibitor 2-7-(3,4-dimethoxyphenyl)-imidazo[1,2-pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents
- Yamamoto N, Takeshita K, Shichijo M, et al. The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-pyrimidin-5- ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. J Pharmacol Exp Ther 2003;306(3):1174-1181
- (2003) J Pharmacol Exp Ther , vol.306 , Issue.3 , pp. 1174-1181
- Yamamoto, N.¹ Takeshita, K.² Shichijo, M.³

6
- 48449090526
- A novel Syk family kinase inhibitor: Design, synthesis, and structure-activity relationship of 1,2,4-triazolo[4,3-c] pyrimidine and 1,2,4-triazolo[1,5-c] pyrimidine derivatives
- Hirabayashi A, Mukaiyama H, Kobayashi H, et al. A novel Syk family kinase inhibitor: design, synthesis, and structure-activity relationship of 1,2,4-triazolo[4,3-c] pyrimidine and 1,2,4-triazolo[1,5-c] pyrimidine derivatives. Bioorg Med Chem 2008;16(15):7347-7357
- (2008) Bioorg Med Chem , vol.16 , Issue.15 , pp. 7347-7357
- Hirabayashi, A.¹ Mukaiyama, H.² Kobayashi, H.³

7
- 0037451847
- Discovery and SAR of novel [1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK)
- DOI 10.1016/S0960-894X(03)00163-X
- Cywin CL, Zhao BP, McNeil DW, et al. Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK). Bioorg Med Chem Lett 2003;13(8):1415-1418 (Pubitemid 36369179)
- (2003) Bioorganic and Medicinal Chemistry Letters , vol.13 , Issue.8 , pp. 1415-1418
- Cywin, C.L.¹ Zhao, B.-P.² McNeil, D.W.³ Hrapchak, M.⁴ Prokopowicz III, A.S.⁵ Goldberg, D.R.⁶ Morwick, T.M.⁷ Gao, A.⁸ Jakes, S.⁹ Kashem, M.¹⁰ Magolda, R.L.¹¹ Soll, R.M.¹² Player, M.R.¹³ Bobko, M.A.¹⁴ Rinker, J.¹⁵ Desjarlais, R.L.¹⁶ Winters, M.P.¹⁷

8
- 33748058807
- Identification of the Syk kinase inhibitor R112 by a human mast cell screen
- DOI 10.1016/j.jaci.2006.05.023, PII S0091674906011985
- Rossi AB, Herlaar E, Braselmann S, et al. Identification of the Syk kinase inhibitor R112 by a human mast cell screen. J Allergy Clin Immunol 2006;118(3):749-755 (Pubitemid 44301399)
- (2006) Journal of Allergy and Clinical Immunology , vol.118 , Issue.3 , pp. 749-755
- Rossi, A.B.¹ Herlaar, E.² Braselmann, S.³ Huynh, S.⁴ Taylor, V.⁵ Frances, R.⁶ Issakani, S.D.⁷ Argade, A.⁸ Singh, R.⁹ Payan, D.G.¹⁰ Masuda, E.S.¹¹

9
- 62249125407
- Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases
- Bajpai M. Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases. IDrugs 2009;12(3):174-185
- (2009) IDrugs , vol.12 , Issue.3 , pp. 174-185
- Bajpai, M.¹

10
- 70349768863
- Rigel Pharmaceuticals, Inc., WO03063794
- Rigel Pharmaceuticals, Inc., 2,4-Pyrimidinediamine Compounds And Their Uses. WO03063794; 2003
- (2003) 2,4-Pyrimidinediamine Compounds and Their Uses

11
- 70349760730
- Available from
- Available from: http://www.rigel.com/rigel/aa

12
- 70349759027
- Available from
- A study to assess the effect Of PF-03526299 on lung function following an allergen challenge in asthmatic subjects NCT00877539. Available from: http://clinicaltrials.gov
- A Study to Assess the Effect of PF-03526299 on Lung Function Following An Allergen Challenge in Asthmatic Subjects NCT00877539

13
- 70349760729
- 14 May 2009
- Vipul Patel at Inflammation 2009, 14 May 2009
- (2009) Inflammation
- Patel, V.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.